Fifth Lane Capital’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Fifth Lane Capital’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,200	Closed	-$357K	–	205
2024 Q1	$357K	Buy	+10,200	New	+$372K	0.31%	49

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Fifth Lane Capital's INBX Position: Q2 2024 in Review

Fifth Lane Capital sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 10,200 shares — an estimated $357K sold.

Fifth Lane Capital first reported a position in INBX in Q1 2024 and held it in 1 quarter. The position peaked at $357K in Q1 2024. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

Fifth Lane Capital reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Fifth Lane Capital sold 10,200 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $357K.
Fifth Lane Capital first reported a position in Inhibrx, Inc. Common Stock in Q1 2024 and held it in 1 quarter.
Fifth Lane Capital's Inhibrx, Inc. Common Stock position peaked at $357K in Q1 2024.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Fifth Lane Capital's 13F filing for Q2 2024, filed 14 Aug 2024.